Revive Therapeutics Announces Submission of IRB Approval for Phase 3 Clinical Trial Protocol for Bucillamine in COVID-19 Pharmaceutical Investing
Cardiol Therapeutics Initiates Health Canada Approved Phase 1 Clinical Study of CardiolRx(TM) Pharmaceutical Investing
Perimeter Medical Imaging AI Announces Appointment of Aaron Davidson as Director Medical Device Investing
Sona Nanotech Announces Clinical Evaluation Study Results for its COVID-19 Antigen Test Biotech Investing
BriaCell Presents Clinical and Scientific Findings at the Annual Symposium of Society of Surgical Oncology 2020 Biotech Investing
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site
